AMGN
Price
$284.32
Change
-$1.98 (-0.69%)
Updated
Mar 28, 6:59 PM EST
26 days until earnings call
LLY
Price
$776.59
Change
-$2.10 (-0.27%)
Updated
Mar 28, 6:59 PM EST
33 days until earnings call
Ad is loading...

Analysis and predictions AMGN vs LLY

Header iconAMGN vs LLY Comparison
Open Charts AMGN vs LLYBanner chart's image
Amgen
Price$284.32
Change-$1.98 (-0.69%)
Volume$1.3M
CapitalizationN/A
Eli Lilly & Co
Price$776.59
Change-$2.10 (-0.27%)
Volume$717.07K
CapitalizationN/A
View a ticker or compare two or three
AMGN vs LLY Comparison Chart

Loading...

AMGNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
LLYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
AMGN vs. LLY commentary
Mar 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMGN is a Hold and LLY is a Hold.

COMPARISON
Comparison
Mar 29, 2024
Stock price -- (AMGN: $284.26 vs. LLY: $777.96)
Brand notoriety: AMGN and LLY are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: AMGN: 48% vs. LLY: 98%
Market capitalization -- AMGN: $152.34B vs. LLY: $739.66B
AMGN [@Pharmaceuticals: Major] is valued at $152.34B. LLY’s [@Pharmaceuticals: Major] market capitalization is $739.66B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $87.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMGN’s FA Score shows that 3 FA rating(s) are green whileLLY’s FA Score has 4 green FA rating(s).

  • AMGN’s FA Score: 3 green, 2 red.
  • LLY’s FA Score: 4 green, 1 red.
According to our system of comparison, AMGN is a better buy in the long-term than LLY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMGN’s TA Score shows that 4 TA indicator(s) are bullish while LLY’s TA Score has 4 bullish TA indicator(s).

  • AMGN’s TA Score: 4 bullish, 4 bearish.
  • LLY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, AMGN is a better buy in the short-term than LLY.

Price Growth

AMGN (@Pharmaceuticals: Major) experienced а +2.64% price change this week, while LLY (@Pharmaceuticals: Major) price change was +1.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.67%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was -2.01%.

Reported Earning Dates

AMGN is expected to report earnings on Apr 24, 2024.

LLY is expected to report earnings on Apr 30, 2024.

Industries' Descriptions

@Pharmaceuticals: Major (+0.67% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
A.I.dvisor published
a Summary for AMGN with price predictions.
OPEN
A.I.dvisor published
a Summary for LLY with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
LLY($740B) has a higher market cap than AMGN($152B). LLY has higher P/E ratio than AMGN: LLY (134.17) vs AMGN (22.76). LLY YTD gains are higher at: 33.458 vs. AMGN (-0.537). AMGN has higher annual earnings (EBITDA): 14.8B vs. LLY (8.57B). AMGN has more cash in the bank: 10.9B vs. LLY (2.93B). LLY has less debt than AMGN: LLY (25.2B) vs AMGN (64.6B). LLY has higher revenues than AMGN: LLY (34.1B) vs AMGN (28.2B).
AMGNLLYAMGN / LLY
Capitalization152B740B21%
EBITDA14.8B8.57B173%
Gain YTD-0.53733.458-2%
P/E Ratio22.76134.1717%
Revenue28.2B34.1B83%
Total Cash10.9B2.93B372%
Total Debt64.6B25.2B256%
FUNDAMENTALS RATINGS
AMGN vs LLY: Fundamental Ratings
AMGN
LLY
OUTLOOK RATING
1..100
531
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
85
Overvalued
PROFIT vs RISK RATING
1..100
131
SMR RATING
1..100
1219
PRICE GROWTH RATING
1..100
5150
P/E GROWTH RATING
1..100
498
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AMGN's Valuation (16) in the Biotechnology industry is significantly better than the same rating for LLY (85) in the Pharmaceuticals Major industry. This means that AMGN’s stock grew significantly faster than LLY’s over the last 12 months.

LLY's Profit vs Risk Rating (1) in the Pharmaceuticals Major industry is in the same range as AMGN (13) in the Biotechnology industry. This means that LLY’s stock grew similarly to AMGN’s over the last 12 months.

AMGN's SMR Rating (12) in the Biotechnology industry is in the same range as LLY (19) in the Pharmaceuticals Major industry. This means that AMGN’s stock grew similarly to LLY’s over the last 12 months.

LLY's Price Growth Rating (50) in the Pharmaceuticals Major industry is in the same range as AMGN (51) in the Biotechnology industry. This means that LLY’s stock grew similarly to AMGN’s over the last 12 months.

LLY's P/E Growth Rating (8) in the Pharmaceuticals Major industry is somewhat better than the same rating for AMGN (49) in the Biotechnology industry. This means that LLY’s stock grew somewhat faster than AMGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMGNLLY
RSI
ODDS (%)
Bullish Trend 1 day ago
63%
Bearish Trend 1 day ago
46%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
44%
Bearish Trend 1 day ago
43%
Momentum
ODDS (%)
Bullish Trend 1 day ago
59%
Bullish Trend 1 day ago
67%
MACD
ODDS (%)
Bullish Trend 1 day ago
60%
Bearish Trend 1 day ago
55%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
71%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
55%
Bullish Trend 1 day ago
71%
Advances
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
68%
Declines
ODDS (%)
Bearish Trend 14 days ago
54%
Bearish Trend 18 days ago
53%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
50%
Bullish Trend 1 day ago
65%
Aroon
ODDS (%)
Bearish Trend 1 day ago
45%
Bullish Trend 1 day ago
75%
View a ticker or compare two or three
Ad is loading...
AMGNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
LLYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OUST7.931.23
+18.36%
Ouster
AGE11.10N/A
N/A
AgeX Therapeutics
MSGS184.46-0.32
-0.17%
Madison Square Garden Sports Corp
FERG218.47-0.48
-0.22%
Ferguson plc
IMTX10.51-0.59
-5.32%
Immatics NV

LLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, LLY has been loosely correlated with NVS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if LLY jumps, then NVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LLY
1D Price
Change %
LLY100%
-0.20%
NVS - LLY
42%
Loosely correlated
+0.89%
MRK - LLY
31%
Poorly correlated
+0.13%
GSK - LLY
31%
Poorly correlated
-0.30%
AMGN - LLY
28%
Poorly correlated
-0.70%
OGN - LLY
25%
Poorly correlated
+1.84%
More